Corient Private Wealth’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$337K Sell
6,073
-12,754
-68% -$744K ﹤0.01% 2256
2025
Q4
$411K Buy
18,827
+12,991
+223% +$707K ﹤0.01% 2427
2025
Q3
$316K Sell
5,836
-514
-8% -$29.4K ﹤0.01% 2083
2025
Q2
$349K Buy
6,350
+1,616
+34% +$95.2K ﹤0.01% 1905
2025
Q1
$335K Buy
+4,734
New +$318K ﹤0.01% 1801
2024
Q3
Sell
-4,286
Closed -$353K 2477
2024
Q2
$353K Sell
4,286
-322
-7% -$26.8K ﹤0.01% 1817
2024
Q1
$402K Buy
4,608
+109
+2% +$9.76K ﹤0.01% 1741
2023
Q4
$434K Buy
4,499
+429
+11% +$38K ﹤0.01% 1682
2023
Q3
$361K Sell
4,070
-29
-0.7% -$2.58K ﹤0.01% 1655
2023
Q2
$355K Buy
4,099
+172
+4% +$16.2K ﹤0.01% 1622
2023
Q1
$382K Sell
3,927
-28
-0.7% -$2.9K ﹤0.01% 1488
2022
Q4
$409K Buy
+3,955
New +$371K ﹤0.01% 1214

Other funds holding BMRN